Surgical Planning Associates — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Surgical Planning Associates is a pioneer in mixed reality surgical navigation, having achieved FDA clearance for its HipInsight™ System 2.0 in August 2024. The company's core technology integrates cloud-based preoperative planning with Microsoft HoloLens 2 to provide intraoperative guidance for hip replacements, aiming to improve implant placement accuracy and surgical efficiency. With over 3,000 procedures completed and a technology base used in more than 11,000 surgeries globally, SPA is transitioning from development to commercial scaling. The leadership team combines deep clinical orthopedic expertise with business and operational experience from top-tier institutions.

OrthopedicsMusculoskeletal

Technology Platform

Mixed reality (Microsoft HoloLens 2) surgical navigation platform integrating cloud-based 3D preoperative planning, automated holographic registration, real-time instrument tracking, and intraoperative virtual guidance for orthopedic surgery.

Opportunities

The large and growing global hip replacement market, combined with a shift towards value-based care, creates a significant opportunity for a cost-effective, accuracy-improving technology like HipInsight.

The platform's scalability and foundation in mixed reality also present a clear pathway for expansion into other orthopedic procedures such as knee and shoulder arthroplasty.

Risk Factors

Primary risks include slow adoption by surgeons accustomed to traditional techniques, intense competition from well-capitalized players in surgical navigation and robotics, and challenges in securing favorable reimbursement from healthcare payers.

Execution risks in scaling manufacturing, support, and training as a small private company are also notable.

Competitive Landscape

SPA competes with established giants in computer-assisted surgery (e.g., Stryker, Zimmer Biomet, Smith & Nephew) and robotic surgery systems, which offer integrated implant portfolios and strong sales networks. HipInsight differentiates itself as a lower-cost, less intrusive mixed reality solution that aims to enhance surgeon vision and decision-making without the high capital expense or bulky equipment of robotic systems.

More companies in Digital Health & Biotech SaaS →More companies in United States →